GAUDIO, Eugenio
 Distribuzione geografica
Continente #
NA - Nord America 256
EU - Europa 120
AS - Asia 77
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 457
Nazione #
US - Stati Uniti d'America 248
IT - Italia 62
SG - Singapore 44
CN - Cina 20
GB - Regno Unito 20
DE - Germania 13
SE - Svezia 13
CA - Canada 8
IN - India 8
CZ - Repubblica Ceca 5
EU - Europa 3
HK - Hong Kong 3
FI - Finlandia 2
FR - Francia 2
NL - Olanda 2
IR - Iran 1
MU - Mauritius 1
MY - Malesia 1
UA - Ucraina 1
Totale 457
Città #
Chandler 48
Singapore 36
Santa Clara 23
Ashburn 20
London 20
Catanzaro 14
Chicago 13
Milan 12
Princeton 12
Lawrence 11
Wilmington 8
Ottawa 6
Luni 5
Olomouc 5
Des Moines 4
Hanover 4
Pune 4
Munich 3
Rome 3
Assago 2
Bathinda 2
Boardman 2
Guangzhou 2
Helsinki 2
Leawood 2
Los Angeles 2
Padova 2
Paris 2
Peterborough 2
Pontedera 2
Troina 2
Wan Chai 2
Washington 2
Amsterdam 1
Ann Arbor 1
Aversa 1
Chongqing 1
Cupertino 1
Hong Kong 1
Kuala Lumpur 1
Mumbai 1
Nagold 1
Norwalk 1
Parsberg 1
Phoenix 1
Pingdingshan 1
Port Louis 1
Rende 1
San Mateo 1
Seattle 1
Secaucus 1
Settingiano 1
Shanghai 1
Shaoxing 1
Shenyang 1
Shenzhen 1
Stezzano 1
Torre Del Lago 1
Treviso 1
Vancouver 1
Totale 306
Nome #
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 41
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 39
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 35
A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells 32
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 31
TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line. 29
Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells 29
A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis 28
Pyrrolo[2′,3′:3,4]cyclohepta[1,2- d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types 28
BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo 27
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation 22
Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis 22
Fhit delocalizes Annexin A4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel 19
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 19
PTPRJ agonist peptides effectively inhibit in vitro cancer cell proliferation and tube formation 19
Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328 17
null 14
The Tumour Suppressor Fhit Protein Activates C-Raf Ubiquitination and Degradation in Human Melanoma Cells by Interacting with Hsp90 12
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas 12
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma 9
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells 6
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas 5
A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers 4
A first-in-class Wiskott-Aldrich syndrome protein (WASp) activator with anti-tumor activity in hematological cancers 2
Totale 501
Categoria #
all - tutte 6.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 2 1 0 0 6
2020/202147 2 0 2 0 0 13 23 0 0 6 1 0
2021/202243 0 0 0 12 2 2 0 10 5 7 5 0
2022/2023147 23 8 12 14 14 13 4 13 22 10 10 4
2023/2024127 20 17 3 13 7 44 3 2 1 1 6 10
2024/2025125 32 8 13 7 32 31 2 0 0 0 0 0
Totale 501